HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P E Schwartz Selected Research

Papillary Adenocarcinoma

9/2010hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma.
1/2010In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P E Schwartz Research Topics

Disease

11Neoplasms (Cancer)
07/2013 - 09/2000
6Ovarian Neoplasms (Ovarian Cancer)
07/2013 - 04/2001
5Carcinoma (Carcinomatosis)
07/2013 - 02/2001
3Endometrial Neoplasms (Endometrial Cancer)
01/2021 - 03/2013
3Ovarian Epithelial Carcinoma
10/2012 - 08/2003
2Disease Progression
03/2013 - 03/2003
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2011 - 02/2001
2Papillary Adenocarcinoma
09/2010 - 01/2010
2Adenocarcinoma
02/2001 - 04/2000
1Microsatellite Instability
01/2021
1Carcinogenesis
07/2013
1Breast Neoplasms (Breast Cancer)
07/2013
1Papillary Carcinoma
09/2010
1Ascites
08/2008
1Dementia (Dementias)
05/2008
1Delirium
05/2008
1Uterine Diseases (Endometrial Disease)
12/2004
1Infections
02/2001
1Teratoma (Teratoid Tumor)
10/2000
1Dysgerminoma
10/2000
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2000

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
07/2013 - 09/2010
3Biomarkers (Surrogate Marker)IBA
07/2013 - 07/2009
3Trastuzumab (Herceptin)FDA Link
04/2012 - 01/2010
2PlatinumIBA
10/2012 - 12/2004
1pembrolizumabIBA
01/2021
1AfatinibIBA
10/2014
1Mammaglobin BIBA
07/2013
1AntigensIBA
07/2013
11-oleoyl-2-stearoylphosphatidylcholineIBA
07/2013
1AntibodiesIBA
07/2013
1Axl Receptor Tyrosine KinaseIBA
07/2013
1ridaforolimusIBA
03/2013
1TOR Serine-Threonine KinasesIBA
03/2013
13' Untranslated Regions (3' UTR)IBA
10/2012
1MicroRNAs (MicroRNA)IBA
10/2012
1Small Interfering RNA (siRNA)IBA
04/2012
1Complement System Proteins (Complement)IBA
04/2012
1Complement Inactivating AgentsIBA
04/2012
1Epidermal Growth Factor (EGF)IBA
10/2011
1Cyclin D1IBA
01/2011
1RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2011
1Thromboplastin (Tissue Factor)IBA
09/2010
1A-factor (Streptomyces)IBA
09/2010
1Rituximab (Mabthera)FDA Link
09/2010
1hI-con1IBA
09/2010
1pertuzumabIBA
01/2010
1Serum Amyloid A Protein (Serum Amyloid A)IBA
07/2009
1NF-kappa B (NF-kB)IBA
08/2008
1CytokinesIBA
08/2008
1AlbuminsIBA
05/2008
1Narcotics (Narcotic Analgesics)IBA
05/2008
1Oxygen (Dioxygen)IBA
05/2008
1Carboplatin (JM8)FDA LinkGeneric
01/2008
1IfosfamideFDA LinkGeneric
01/2008
1Cisplatin (Platino)FDA LinkGeneric
01/2008
1Paclitaxel (Taxol)FDA LinkGeneric
01/2008
1Tumor Biomarkers (Tumor Markers)IBA
08/2003
1Topoisomerase I InhibitorsIBA
03/2003
1Topotecan (Hycamtin)FDA LinkGeneric
03/2003
1Oral ContraceptivesIBA
12/2001
1CA-125 Antigen (CA 125 Antigen)IBA
04/2001
1DNA (Deoxyribonucleic Acid)IBA
02/2001
1Polyethylene Terephthalates (Polyethylene Terephthalate)IBA
02/2001
1Antineoplastic Agents (Antineoplastics)IBA
09/2000
1Estrogens (Estrogen)FDA Link
04/2000
1Hormones (Hormone)IBA
04/2000

Therapy/Procedure

5Drug Therapy (Chemotherapy)
07/2013 - 10/2000
4Immunotherapy
07/2013 - 09/2010
4Therapeutics
10/2012 - 09/2000
1Catheters
05/2008
1Brachytherapy
12/2004
1Hysterectomy
12/2004
1Ovariectomy (Oophorectomy)
12/2001
1Tubal Sterilization (Tubal Ligation)
12/2001
1Cystectomy
10/2000
1Cytoreduction Surgical Procedures
10/2000
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
04/2000